Corbion Nv · EURONEXT:CRBN

Corbion Nv — Q1 2020 Earnings Presentation

10 slides from Corbion Nv's earnings presentation, Apr 30, 2020

  1. Slide 1: Q1 2020 Results

    Q1 2020 RESULTS OLIVIER RIGAUD (CEO) / EDDY VAN 30/4/2020 Photo © Total Corbion PLA RHEDE VAN DER KLOOT (CFO)

  2. Slide 2: Highlights Q1 2020

    Highlights Q1 2020 • Organic net sales increase of 9.6%, volume driven • Core activities (+11.1%) • Sustainable Food Solutions: Strong start of quarter, further boosted by COVID-19 impact • Lactic Acid & Specialties: High growth in lactic acid; recovery semiconductor industry • Incubator: Strong sal

  3. Slide 3: Net sales and Adjusted EBITDA: YTD/Q1 2020

    Net sales and Adjusted EBITDA: YTD/Q1 2020 € million YTD 2020 YTD 2019 Growth YTD Net Sales Core 215.2 187.2 15.0% - Sustainable Food Solutions 136.2 120.1 13.4% - Lactic Acid & Specialties 76.7 65.7 16.7% - Incubator 2.3 1.4 64.3% Non-Core 41.1 41.7 -1.4% Total Net Sales 256.3 228.9 12.0% Adjusted

  4. Slide 4: Sales Growth per segment in YTD/Q1 2020

    Sales Growth per segment in YTD/Q1 2020 Total growth at Acquisitions/ Net sales Total growth Currency Organic Price/Mix Volume constant currency (Divestments) YTD 2020 vs YTD 2019 Core 15.0% 1.3% 13.7% 2.6% 11.1% -3.6% 15.3% - Sustainable Food Solutions 13.4% 1.1% 12.3% 4.0% 8.3% -0.6% 9.0% - Lactic

  5. Slide 5: Sustainable Food Solutions

    Sustainable Food Solutions YTD YTD YTD 2020 key items € million 2020 2019 Net sales 136.2 120.1 • Functional Systems: Strong growth Organic growth 8.3% as customers were securing supply, and consumers were shifting to Adjusted EBITDA 24.5 21.1 packaged bread Adjusted EBITDA % 18.0% 17.6% • Preservat

  6. Slide 6: Lactic Acid & Specialties

    Lactic Acid & Specialties YTD YTD YTD 2020 key items € million 2020 2019 Net sales 76.7 65.7 • High growth in lactic acid, both for Organic growth 14.7% PLA and other applications • Recovery in esters (solvents) for Adjusted EBITDA 19.2 15.5 Adjusted EBITDA % 25.0% 23.6% semiconductors • Lactates (p

  7. Slide 7: Incubator & Non-core activities

    Incubator & Non-core activities INCUBATOR • Sales growth driven by higher AlgaPrime DHA (omega-3 YTD YTD sales) € million 2020 2019 Net sales 2.3 1.4 • Supported by liquid product version Organic growth 86.6% Adjusted EBITDA (5.7) (7.7) Adjusted EBITDA % -247.8% -550.0% NON-CORE ACTIVITIES • Higher

  8. Slide 8: Core Adjusted EBITDA bridge YTD 2020

    Core Adjusted EBITDA bridge YTD 2020 50.0 Core activities 14.0 • Organic increase due to 40.0 2.3 1.0 0.3 higher volumes 4.0 • Pricing/mix slightly lower 30.0 • Small positive currency impact 20.0 38.0 28.9 10.0 0.0 Adj. EBITDA Volumes Pricing and Costs Currency Acquisitions Adj. EBITDA Core YTD mix

  9. Slide 9: Outlook FY 2020

    Outlook FY 2020 • Q1 results exceeded indicated annual guidance levels • No change to guidance due to COVID-19 uncertainty • 2020 guidance for core activities: • Organic net sales growth in the 4-7% range • Adjusted EBITDA margin stable vs FY19 at ~15% 9 © 30/4/2020

  10. Slide 10: Slide 10

Corbion — Q1 2020 Earnings Presentation on 6ix